65239-69-2

Basic information

• Product Name: 2,4-dihydroxy-3-propyl-1',1',1'-trifluoroacetophenone
• Synonyms: 2,4-dihydroxy-3-propyl-1',1',1'-trifluoroacetophenone
• CAS NO: 65239-69-2
• Molecular Weight: 248.202
• Mol File: 65239-69-2.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 2,4-dihydroxy-3-propyl-1',1',1'-trifluoroacetophenone(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-dihydroxy-3-propyl-1',1',1'-trifluoroacetophenone(65239-69-2)
• EPA Substance Registry System: 2,4-dihydroxy-3-propyl-1',1',1'-trifluoroacetophenone(65239-69-2)

Safety Data

• Hazardous Substances Data: 65239-69-2(Hazardous Substances Data)

Usage

General Description

2,4-dihydroxy-3-propyl-1',1',1'-trifluoroacetophenone is a chemical compound with a complex structure that includes a trifluoroacetophenone backbone with a propyl and two hydroxyl groups attached. 2,4-dihydroxy-3-propyl-1',1',1'-trifluoroacetophenone is commonly used as a building block in organic synthesis and pharmaceutical research. Its unique structure and functional groups make it a valuable intermediate in the production of various pharmaceuticals and agrochemicals. Additionally, the trifluoroacetophenone moiety in this compound provides enhanced reactivity and selectivity, making it a versatile tool for the synthesis of complex organic molecules. Due to its potential applications in various fields, 2,4-dihydroxy-3-propyl-1',1',1'-trifluoroacetophenone is of interest to researchers and chemists.

Upstream product

• 151-10-0 1,3-Dimethoxybenzene 
• 16929-64-9 1,3-Dimethoxy-2-(prop-1'-yl)benzene 
• 315-44-6 2,4-dihydroxy-1’,1’,1’-trifluoroacetophenone 
• 709028-25-1 1-(3-allyl-2,4-dihydroxy-phenyl)-2,2,2-trifluoro-ethanone 
• 353-85-5 trifluoroacetonitrile 
• 13331-19-6 2-propyl-1,3-benzenediol 
• 407-25-0 trifluoroacetic anhydride 

Downstream Products

• 118683-21-9 4-{[4-(trifluoroacetyl)-3-hydroxy-2-propylphenoxy]methyl}benzoic acid 
• 709028-30-8 {3-Chloro-4-[3-(3-hydroxy-2-propyl-4-{2,2,2-trifluoro-1-[(Z)-hydroxyimino]-ethyl}-phenoxy)-propylsulfanyl]-phenyl}-acetic acid methyl ester 
• 194608-89-4 {3-chloro-4-[3-(7-propyl-3-trifluoromethyl-benzo[d]isoxazol-6-yloxy)-propylsulfanyl]-phenyl}-acetic acid methyl ester 
• 194608-88-3 7-dipropyl-6-hydroxy-3-trifluoromethyl-1,2-benzisoxazole 
• 724471-16-3 2,4-dihydroxy-3-dipropyl-1',1',1'-trifluoroacetophenone oxime 
• 709028-29-5 (3-Chloro-4-{3-[3-hydroxy-2-propyl-4-(2,2,2-trifluoro-acetyl)-phenoxy]-propylsulfanyl}-phenyl)-acetic acid methyl ester 
• 118684-12-1 2-tetrahydropyranyl 4-<<4-(trifluoroacetyl)-3-hydroxy-2-propylphenoxy>methyl>benzoate 

Relevant articles and documents

THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS

The present invention relates to novel LXR ligands of Formula (I) and pharmaceutically acceptable salts, esters and tautomers thereof, which are useful in the treatment of dyslipidemic conditions, particularly depressed levels of HDL cholesterol.

Discovery of a novel series of peroxisome proliferator-activated receptor α/γ dual agonists for the treatment of type 2 diabetes and dyslipidemia

A series of 2-aryloxy-2-methyl-propionic acid compounds and related analogues were designed, synthesized, and evaluated for their PPAR agonist activities. 2-[(5,7-Dipropyl-3-trifluoromethyl)-benzisoxazol-6-yloxy]-2- methylpropionic acid (4) was identified

THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS

The present invention relates to novel LXR ligands of Formula I and the pharmaceutically acceptable salts, esters and tautomers thereof, which are useful in the treatment of dyslipidemic conditions, particularly depressed levels of HDL cholesterol.